Mirk-IN-1

• CAT Number: I001490
• CAS Number: 1386979-55-0
• Molecular Formula: C23H17Cl2N5O4
• Molecular Weight: 498.32
• Purity: ≥95%
• Target: DYRK
• Solubility: 10 mM in DMSO
• Storage: Store at -20C
• IC50: 68±48/22±8 nM (Dyrk1B/Dyrk1A) [1]

Mirk-IN-1 (Cat.No:I001490) is a selective inhibitor of the Mirk/Dyrk1B kinase, a member of the dual-specificity tyrosine-regulated kinase family. By targeting Mirk/Dyrk1B, Mirk-IN-1 inhibits its kinase activity, leading to suppression of cell proliferation and induction of cell cycle arrest. Mirk-IN-1 shows potential as an anticancer agent, particularly in breast and pancreatic cancers.

Reference

[1]. Ewton DZ, et al. Inactivation of mirk/dyrk1b kinase targets quiescent pancreatic cancer cells. Mol Cancer Ther. 2011 Nov;10(11):2104-14.
[2]. Anderson K, et al. Pyrido[2,3-d]pyrimidines: discovery and preliminary SAR of a novel series of DYRK1B and DYRK1A inhibitors. Bioorg Med Chem Lett. 2013 Dec 15;23(24):6610-5.